// App-Quantinova.ai

: ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001

Researchers

Presenter

  • Vijayananda Kundapur

Principal Investigators

  • Kiran Devisetty

  • Sunjay Shah

  • Kenneth Usuki

  • Andrew Baschnagel

  • Baldassarre Stea

  • Harold Yoon

  • Jing Li

  • Nadia Laack

  • Minesh Mehta

  • Lisa Kachnic

Medical Centers

  • Saskatoon Cancer Centre, Saskatoon, SK, Canada

  • Wayne State University Karmanos Cancer Institute, Detroit, MI

  • McLaren Cancer Institute - Flint (ACCRUALS UNDER Delaware/Christiana Care NCI Community Oncology Research Program), Mclaran, USA

  • University of Rochester, Rochester, NY

  • University of Wisconsin Hosp and Clinics, Madison, WI

  • University of Arizona, Tucson, AZ

  • Heartland Cancer Research NCORP, Springfield, USA

  • Mayo Clinic/Accruals for Rochester Methodist Hospital (NCCTG), Rochester, MN, USA

  • Baptist Health, Miami, FL

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Brain cancer

Biomarkers

  • N/A

Drug/Treatment

  • Memantine

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved